Bottom line
What is MVGAX's expense ratio?
MVGAX's expense ratio is 0.99%, or about $99 a year on every $10,000 invested. That is more expensive than 55% of global stock funds we track (median 0.95%). This share class also charges a front-end sales load of up to 5.75%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Dec 29, 2025
MVGAX fee table
| Net expense ratio | 0.99% |
|---|---|
| Gross expense ratio | 1.02% |
| Management fee | 0.55% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.22% |
| Fee waiver / reimbursement | -0.03% |
| Max front-end sales load | 5.75% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Dec 29, 2025
What MVGAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| MVGAX | $670 | $878 | $1,103 | $1,749 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.99% expense ratio costs roughly $54,900 in lost growth, versus about $52,800 for the median global stock fund (0.95%).